A kallidin-like peptide is a protective cardiac kinin, released by ischaemic preconditioning of rat heart

British Journal of Pharmacology

Volumn 146, Issue 7, 2005, Pages 952-957

  Liu, Xiuxin ^a   Lukasova, Martina ^a   Zubakova, Radka ^a   Lewicka, Sabina ^a   Hilgenfeldt, Ulrich ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bradykinin; Creatine kinase activity; HOE140; Isolated perfused rat hearts; Kallidin antiserum; Kallidin like peptide; Myocardial ischaemic preconditioning

Indexed keywords

ICATIBANT; KALLIDIN DERIVATIVE; KININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EVALUATION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; KALLIKREIN KININ SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANIMALS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; KALLIDIN; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 28444485656     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706402     Document Type: Article

References (26)

1. BOUCHARD, J.F., CHOUINARD, J. & LAMONTAGNE, D. (1998). Role of kinins in the endothelial protective effect of ischaemic preconditioning. Br. J. Pharmacol., 123, 413-420.
2. BUGGE, E. & YTREHUS, K. (1996). Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart. J. Mol. Cell. Cardiol., 28, 2333-2342.
3. FENG, J. & ROSENKRANZ, E.R. (1999). Bradykinin pretreatment improves ischemia tolerance of the rabbit heart by tyrosine kinase mediated pathways. Ann. Thorac. Surg., 68, 1567-1572.
4. FRYER, R.M., AUCHAMPACH, J.A. & GROSS, G.J. (2002). Therapeutic receptor targets of ischemic preconditioning. Cardiovasc. Res., 55, 520-525.
5. GOTO, M., LIU, Y., YANG, X.M., ARDELL, J.L., COHEN, M.V. & DOWNEY, J.M. (1995). Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ. Res., 77, 611-621.
6. HILGENFELDT, U., LINKE, R., RIESTER, U., KÖNIG, W. & BREIPOHL, G. (1995). Strategy of measuring bradykinin and kallidin and their concentration in plasma and urine. Anal. Biochem., 228, 35-41.
7. HILGENFELDT, U., PUSCHNER, T., RIESTER, U., FINSTERLE, J., HILGENFELDT, J. & RITZ, E. (1998). Low-salt downregulates plasma but not tissue kallikrein-kinin system. Am. J. Physiol., 44, F88-F93.
8. HILGENFELDT, U., STANNEK, C., LUKASOVA, M., SCHNÖLZER, M. & LEWICKA, S. (2005). Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular weight kininogen. Br. J. Pharmacol., 146, 958-963 (this issue).
9. KATO, H., ENJYOJI, K., MIYATA, T., HAYASHI, I., OH-ISHI, S. & IWANAGA, S. (1985). Demonstration of arginyl-BK moiety in rat HMW-kininogen: direct evidence for liberation of BK by glandular kallikreins. Biochem. Biophys. Res. Comm., 127, 289-295.
10. KIMURA, E., HASHIMOTO, K., FURUKAWA, S. & HAYAKAWA, H. (1973). Changes in bradykinin levels in coronary sinus blood after the experimental occlusion of a coronary artery. Am. Heart J., 85, 635-647.
11. LEESAR, M.A., STODDARD, M.F., MANCHIKALAPUDI, S. & BOLLI, R. (1999). Bradykinin induces preconditioning in patients undergoing coronary angioplasty. J. Am. Coll. Cardiol., 34, 639-650.
12. LINZ, W., WIEMER, G. & SCHÖLKENS, B. (1997). Beneficial effect of BK on myocardial energy metabolism and infarct size. Am. J. Cardiol., 80, 118A-123A.
13. MATSUKI, T., SHOJI, T., YOSHIDA, S., KUDOH, Y., MOTOE, M., INOUE, M., NAKATA, T., HOSODA, S., SHIMAMOTO, K., YELLON, D. & IMURA, D. (1987). Sympathetically induced myocardial ischemia causes the heart to release plasma kinin. Cardiovasc. Res., 21, 428-432.
14. MURRY, C.E., JENNINGS, R.B. & REIMERS, K.A. (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 75, 1124-1136.
15. NAGAOKA, M., YAYAMA, K., TAKANO, M. & OKAMOTO, H. (1999). Expression of kininogen genes in rat cardiomyocytes. Immunopharmacology, 44, 81-85.
16. NOLLY, H., CARBINI, L.A., SCICLI, G., CARRETERO, O.A. & SCICLI, A.G. (1994). A local kallikrein-kinin system is present in rat hearts. Hypertension, 23, 919-923.
17. PAN, H.L., CHEN, S.R., SCICLI, G.M. & CARRETERO, O.A. (2000). Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning. Am. J. Physiol. Heart. Circ. Physiol., 279, H116-H121.
18. PARRATT, J.R., VEGH, A., ZEITLIN, J., AHMAD, M., OLDROYD, K., KASZALA, K. & PAPP, J.G. (1997). Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning. Am. J. Cardiol., 80, 124A-131A.
19. RUBIN, L.E. & LEVI, R. (1995). Protective role of BK in cardiac anaphylaxis: coronary-vasodilating and antiarrhythmic activities mediated by autocrine/paracrine mechanisms. Circ. Res., 76, 434-440.
20. RUBINO, A. & YELLON, M. (2000). Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart? Trends Pharmacol. Sci., 21, 225-230.
21. SANADA, S. & KITAKAZE, M. (2004). Ischemic preconditioning: emerging evidence, controversy, and translational trials. Int. J. Cardiol., 97, 263-276.
22. SCHULZ, R., POST, H., VAHLHAUS, C. & HEUCH, G. (1998). Ischemic preconditioning in pigs: a graded phenomenon. Its relation to adenosine and bradykinin. Circulation, 98, 1022-1029.
23. SICUTERI, F., FRANCHI, G., DELBIANCO, P.L. & DELBENE, P.L. (1967). A contribution to the interpretation of shock and pain in myocardial infarction. Mallattie Cardiovasc., 8, 343-362.
24. 2-receptors. Br. J. Pharmacol., 113, 1167-1172.
25. WALL, T.M., SHEEHY, R. & HATMAN, C. (1994). Role of bradykinin in myocardial preconditioning. J. Pharmacol. Exp. Ther., 270, 681-689.
26. XIONG, W., CHEN, L.M., WOODY-MILLER, C., SIMSON, J.A.V. & CHAO, J. (1990). Identification, purification, and localization of tissue kallikrein in rat heart. Biochem. J., 267, 639-646.